Robust third quarter sales for life science companies
IBO Stock Indexes rise almost 40% in 2017
Third quarter revenues rise for selected companies
Strong results for Agilent and Bio-Techne
Bio-Rad Laboratories and Illumina show double-digit gains
Sales in China remain robust
IBO Stock Index companies stay steady in third quarter
Second quarter sales growth led by Abcam
IBO Stock Indexes slightly gain traction
Financial results for FY17
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
